Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway
BMC Veterinary Research · 17.05.2024 · 20 (1)
DOI: 10.1186/s12917-024-04055-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Veterinary Research, online erschienen am 17.05.2024. Verfasst von Qi-Lin Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences (CAAS), Lanzhou Gansu, 730000, China. Hauptthemen laut MEDLINE: Actinobacillus Infections, Actinobacillus pleuropneumoniae, Acute Lung Injury, Flavanones. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development fund of Gansu Province, the National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Actinobacillus pleuropneumoniae (APP) causes porcine pleuropneumonia (PCP), which is clinically characterized by acute hemorrhagic, necrotizing pneumonia, and chronic fibrinous pneumonia. Although many measures have been taken to prevent the disease, prevention and control of the disease are becoming increasingly difficult due to the abundance of APP sera, weak vaccine cross-protection, and increasing antibiotic resistance in APP. Therefore, there is an urgent need to develop novel drugs against APP infection to prevent the spread of APP. Naringin (NAR) has been reported to have an excellent therapeutic effect on pulmonary diseases, but its therapeutic effect on lung injury caused by APP is not apparent. Our research has shown that NAR was able to alleviate APP-induced weight loss and quantity of food taken and reduce the number of WBCs and NEs in peripheral blood in mice; pathological tissue sections showed that NAR was able to prevent and control APP-induced pathological lung injury effectively; based on the establishment of an in vivo/in vitro model of APP inflammation, it was found that NAR was able to play an anti-inflammatory role through inhibiting the MAPK/NF-κB signaling pathway and exerting anti-inflammatory effects; additionally, NAR activating the Nrf2 signalling pathway, increasing the secretion of antioxidant enzymes Nqo1, CAT, and SOD1, inhibiting the secretion of oxidative damage factors NOS2 and COX2, and enhancing the antioxidant stress ability, thus playing an antioxidant role. In summary, NAR can relieve severe lung injury caused by APP by reducing excessive inflammatory response and improving antioxidant capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences (CAAS), Lanzhou Gansu, 730000, China.
- Engineering and Technology Research Center of Traditional Chinese Veterinary Medicine of Gansu Province, Lanzhou Gansu, 730000, China.
- Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs of P.R, Lanzhou Gansu, 730000, China.
- School of Pharmacy, State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou Gansu, 730000, China.
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou Gansu, 730000, China.
- Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences (CAAS), Lanzhou Gansu, 730000, China. qiumoying@163.com.
Förderung
- Key Research and Development fund of Gansu Province
- the National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province
- Central government guides local science and technology development fund projects in Gansu province
- Lanzhou Science and Technology Project
Zitieren
APA
Huang, Q. L., Huang, L. N., Zhao, G. Y., Liu, C., Pan, X. Y., Li, Z. R., Jing, X. H., Qiu, Z. Y., & Xin, R. H. (2024). Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway. BMC Veterinary Research, 20(1). https://doi.org/10.1186/s12917-024-04055-2
Vancouver
Huang QL, Huang LN, Zhao GY, Liu C, Pan XY, Li ZR, et al. Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway. BMC Veterinary Research. 2024;20(1). doi:10.1186/s12917-024-04055-2
BibTeX
@article{Huang2024,
author = {Huang, Qi-Lin and Huang, Li-Na and Zhao, Guan-Yu and Liu, Chen and Pan, Xiang-Yi and Li, Zhao-Rong and Jing, Xiao-Han and Qiu, Zheng-Ying and Xin, Rui-Hua},
title = {Naringin attenuates Actinobacillus pleuropneumoniae-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway},
journal = {BMC Veterinary Research},
year = {2024},
volume = {20},
number = {1},
doi = {10.1186/s12917-024-04055-2}
}
EUVIMED